Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2000 June;44(2) > The Quarterly Journal of Nuclear Medicine 2000 June;44(2):112-20

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi

 

  ECONOMICS OF NUCLEAR MEDICINE
Guest Editor: Gambhir S. S.
 

The Quarterly Journal of Nuclear Medicine 2000 June;44(2):112-20

Copyright © 2009 EDIZIONI MINERVA MEDICA

lingua: Inglese

The role of cost effectiveness analysis in health care evaluation

Atherly A., Culler S. D., Becker E. R.

From the Department of Health Policy and Management Rollins School of Public Health Emory University, Atlanta, GA, USA


PDF


This ­paper pro­vides an over­view of the key ele­ments of ­cost effec­tive­ness anal­y­sis (CEA). CEA is a meth­od for eval­u­at­ing the rel­a­tive ­costs and ben­e­fits of treat­ments and pro­ce­dures. Typically, CEA com­pares a pro­posed inter­ven­tion ­with (at ­least) one alter­na­tive inter­ven­tion, yield­ing an incre­men­tal ­cost effec­tive­ness ­ratio. This ­ratio ­reflects ­both the lon­gev­ity and ­health stat­us of the dif­fer­ing inter­ven­tions and per­mits the research­er to ­more com­plete­ly com­pare and eval­u­ate the “pay­off” of the inter­ven­tions. This ­paper dis­cuss­es dif­fer­ent per­spec­tives CEA stud­ies ­might ­adopt, and ­reviews the ­major meth­ods for meas­ur­ing ­both out­comes and ­costs.

inizio pagina